L1CAM and neuroendocrine neoplasm: Expression of L1CAM has been reported as an independent prognostic factor for disease-free survival in ovarian cancer [27], neuroendocrine tumors [28], gallbladder cancer [29], hepatocellular cancer [30] and endometrial cancer [20].